|
|
Temporary Topical external hemostats that are fast, safe, easy to use and effective. Our proprietary chitosan granule technology has been proven to control bleeding on a broad variety of wounds, even in the presence of common anticoagulants and shows many of the characteristics of an ideal hemostat, including cost-effectiveness. (Johnson et al, Milner et al & Snyder & Sigal et al, 2013)
Excessive bleeding can put patients at risk and lead to complications, including death. According to a 2018 review, every year more than 60,000 Americans die from uncontrolled hemorrhage or blood loss.
(Cannon, J. (2018, January 25). Hemorrhagic Shock. The New England Journal of Medicine, 378, 370-9)
Hemostatic agents offer an effective tool to stop excessive bleeding. Hemostats that work independent of the body’s natural clotting cascade may offer benefits to patients with impaired coagulation.
OMNI-STAT® and CELOXTM are powerful hemostatic agents for medical professionals designed to stop difficult to control bleeding on a broad variety of wounds in a diverse patient population. Hemostatic agents can be used for various applications across the hospital including:
Our proprietary technology has been used successfully since 2006 and significant investment has been made to provide a fast, safe and effective solution to control minor, moderate and severe bleeding even in the presence of common anticoagulants (Johnson et al).
OMNI-STAT is indicated for minor external bleeding from wounds and procedures (Rx) is indicated for use as a temporary topical dressing for bleeding control associated with minor wounds, including control of minor external bleeding and exudate from sutures and/or surgical procedures.
OMNI-STAT and CELOX are indicated for moderate to severe external bleeding wounds (Rx) is indicated for temporary external treatment for controlling moderate to severe bleeding.
CELOX Vascular is indicated for the local management and control of surface bleeding (Rx) from vascular access sites, percutaneous catheters or tubes utilizing introducer sheaths up to 16 French.
|
|
15th February 2021 | Evidence of Use, General News
Revascularized Wound : Femoral Tibial Bypass This 48 year old male who was a very heavy smoker, three to four packs a day, required a Femoral anterior tibial bypass. This is a...
More18th January 2021 | General News
Bleeding Control of a Hematoma Pre and Post Surgical Debridement with Hemostatic Gauze and Granules Male patient, late 70’s with Lymphedema, previous Deep Vein Thrombosis (DVT), and chronic COPD who is severely obese...
More1st December 2020 | Evidence of Use, General News
Use of topical hemostat in a clinical setting to control bleeding on an avulsed nail This is a 48 year old chronically obese diabetic who has lymphedema, severe venous insufficiency and Charcot arthropathy....
MorePlease leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
This website uses Cookies to improve your browsing experience. View Cookies Policy
I'm fine with this